17-39161326-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4BP6_Moderate
The NM_001143968.1(ARL5C):c.281C>T(p.Thr94Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000047 in 1,551,754 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001143968.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL5C | NM_001143968.1 | c.281C>T | p.Thr94Met | missense_variant | 4/6 | ENST00000269586.12 | NP_001137440.1 | |
ARL5C | XM_047435964.1 | c.281C>T | p.Thr94Met | missense_variant | 4/6 | XP_047291920.1 | ||
ARL5C | XM_047435963.1 | c.152C>T | p.Thr51Met | missense_variant | 3/4 | XP_047291919.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL5C | ENST00000269586.12 | c.281C>T | p.Thr94Met | missense_variant | 4/6 | 5 | NM_001143968.1 | ENSP00000269586 | P1 | |
ARL5C | ENST00000578912.1 | c.50C>T | p.Thr17Met | missense_variant, NMD_transcript_variant | 2/4 | 4 | ENSP00000466347 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000572 AC: 9AN: 157318Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83256
GnomAD4 exome AF: 0.0000422 AC: 59AN: 1399656Hom.: 0 Cov.: 32 AF XY: 0.0000362 AC XY: 25AN XY: 690328
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74284
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at